Literature DB >> 30358729

Association between the vaginal microbiota, menopause status, and signs of vulvovaginal atrophy.

Rebecca M Brotman1,2, Michelle D Shardell2, Pawel Gajer1, Doug Fadrosh1, Kathryn Chang3, Michelle I Silver3, Raphael P Viscidi4, Anne E Burke5, Jacques Ravel1,6, Patti E Gravitt3.   

Abstract

OBJECTIVE: The vaginal microbiota helps protect the female genital tract from disease. We sought to describe the composition of the vaginal microbiota in premenopausal, perimenopausal, and postmenopausal women and to explore the association between the microbiota and vulvovaginal atrophy (VVA).
METHODS: Eighty-seven women (aged 35-60 y) were classified as premenopausal (n = 30), perimenopausal (n = 29), or postmenopausal (n = 28) according to Stages of Reproductive Aging Workshop guidelines. Midvaginal bacterial community composition was characterized by 16S ribosomal RNA gene analysis.
RESULTS: Bacterial communities clustered into six community state types (CSTs), of which four were dominated by Lactobacillus crispatus, Lactobacillus gasseri, Lactobacillus iners, or Lactobacillus jensenii, and two (CST IV-A and CST IV-B) had low relative abundance of Lactobacillus. CST IV-A was characterized by Streptococcus and Prevotella, whereas CST IV-B was characterized by Atopobium. There were significant associations between menopause stage and CST (P = 0.004) and between VVA and CST (P = 0.002). Perimenopausal women were more likely to be classified as CST IV-A or L. gasseri CST, whereas postmenopausal women were often classified as CST IV-A. CSTs dominated by L. crispatus and L. iners were more prevalent in premenopausal women. Nineteen participants had signs of mild or moderate VVA. Compared with women with no VVA, the vaginal microbiota of women with mild or moderate atrophy had 25-fold greater odds of being classified as CST IV-A versus L. crispatus CST (adjusted odds ratio, 25.89; 95% credible interval, 2.98-406.79).
CONCLUSIONS: A distinct bacterial community state (CST IV-A) with a low relative abundance of Lactobacillus is associated with VVA. Future studies recruiting a larger number of women are needed to replicate the findings. This study provides an impetus for future longitudinal studies designed to manage, modulate, and restore vaginal microbiota homeostasis, which would provide stronger evidence for a causal relationship with VVA and ultimately improve the treatment and prevention of atrophic vaginitis in menopause.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30358729     DOI: 10.1097/GME.0000000000001236

Source DB:  PubMed          Journal:  Menopause        ISSN: 1072-3714            Impact factor:   3.310


  21 in total

1.  Cervicovaginal microbial communities deficient in Lactobacillus species are associated with second trimester short cervix.

Authors:  Kristin D Gerson; Clare McCarthy; Michal A Elovitz; Jacques Ravel; Mary D Sammel; Heather H Burris
Journal:  Am J Obstet Gynecol       Date:  2019-12-06       Impact factor: 8.661

Review 2.  Practical Treatment Considerations in the Management of Genitourinary Syndrome of Menopause.

Authors:  Risa Kagan; Susan Kellogg-Spadt; Sharon J Parish
Journal:  Drugs Aging       Date:  2019-10       Impact factor: 3.923

3.  Effect of sterilization on the canine vaginal microbiota: a pilot study.

Authors:  Ada Rota; Michela Corrò; Ilaria Patuzzi; Chiara Milani; Stefania Masia; Eleonora Mastrorilli; Sara Petrin; Alessandra Longo; Angela Del Carro; Carmen Losasso
Journal:  BMC Vet Res       Date:  2020-11-23       Impact factor: 2.741

4.  Fecal microbiota transplantation mitigates vaginal atrophy in ovariectomized mice.

Authors:  Jia Huang; Wanying Shan; Fuxia Li; Zizhuo Wang; Jing Cheng; Funian Lu; Ensong Guo; Rajluxmee Beejadhursing; Rourou Xiao; Chen Liu; Bin Yang; Xi Li; Yu Fu; Ling Xi; Shixuan Wang; Ding Ma; Gang Chen; Chaoyang Sun
Journal:  Aging (Albany NY)       Date:  2021-02-26       Impact factor: 5.682

Review 5.  The Vaginal Microbiome: A Long Urogenital Colonization Throughout Woman Life.

Authors:  Renata S Auriemma; Roberta Scairati; Guendalina Del Vecchio; Alessia Liccardi; Nunzia Verde; Rosa Pirchio; Rosario Pivonello; Danilo Ercolini; Annamaria Colao
Journal:  Front Cell Infect Microbiol       Date:  2021-07-06       Impact factor: 5.293

Review 6.  Addressing Vulvovaginal Atrophy (VVA)/Genitourinary Syndrome of Menopause (GSM) for Healthy Aging in Women.

Authors:  Rossella E Nappi; Ellis Martini; Laura Cucinella; Silvia Martella; Lara Tiranini; Alessandra Inzoli; Emanuela Brambilla; David Bosoni; Chiara Cassani; Barbara Gardella
Journal:  Front Endocrinol (Lausanne)       Date:  2019-08-21       Impact factor: 5.555

Review 7.  Roles of the vagina and the vaginal microbiota in urinary tract infection: evidence from clinical correlations and experimental models.

Authors:  Amanda L Lewis; Nicole M Gilbert
Journal:  GMS Infect Dis       Date:  2020-03-26

Review 8.  Bacterial Vaginosis: Current Diagnostic Avenues and Future Opportunities.

Authors:  Mathys J Redelinghuys; Janri Geldenhuys; Hyunsul Jung; Marleen M Kock
Journal:  Front Cell Infect Microbiol       Date:  2020-08-11       Impact factor: 5.293

9.  Effect of Vitamin D Supplement on Vulvovaginal Atrophy of the Menopause.

Authors:  Thawinee Kamronrithisorn; Jittima Manonai; Sakda Arj-Ong Vallibhakara; Areepan Sophonsritsuk; Orawin Vallibhakara
Journal:  Nutrients       Date:  2020-09-21       Impact factor: 5.717

10.  Obesity is associated with lower bacterial vaginosis prevalence in menopausal but not pre-menopausal women in a retrospective analysis of the Women's Interagency HIV Study.

Authors:  Elizabeth Daubert; Kathleen M Weber; Audrey L French; Dominika Seidman; Katherine Michel; Deborah Gustafson; Kerry Murphy; Christina A Muzny; Maria Alcaide; Anandi Sheth; Adaora A Adimora; Gregory T Spear
Journal:  PLoS One       Date:  2021-03-08       Impact factor: 3.752

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.